Acima Private Wealth’s Idexx Laboratories IDXX Stock Holding History

Acima Private Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$234K	Sell	449 -44	-9%	-$24.1K	0.07%	106
2026 Q2	$260K	Hold	493	–	–	0.08%	104
2026 Q1	$277K	Hold	493	–	–	0.09%	106
2025 Q4	$334K	Hold	493	–	–	0.1%	97
2025 Q3	$315K	Hold	493	–	–	0.1%	103
2025 Q2	$264K	Hold	493	–	–	0.09%	107
2025 Q1	$207K	Hold	493	–	–	0.07%	116
2024 Q4	$204K	Hold	493	–	–	0.07%	117
2024 Q3	$249K	Hold	493	–	–	0.08%	114
2024 Q2	$240K	Hold	493	–	–	0.09%	111
2024 Q1	$266K	Hold	493	–	–	0.1%	111
2023 Q4	$274K	Hold	493	–	–	0.11%	110
2023 Q3	$216K	Hold	493	–	–	0.1%	122
2023 Q2	$248K	Hold	493	–	–	0.12%	118
2023 Q1	$247K	Buy	+493	New	+$236K	0.12%	116
2020 Q1	–	Sell	-24	Closed	-$6K	–	275
2019 Q4	$6K	Hold	24	–	–	﹤0.01%	258
2019 Q3	$6K	Hold	24	–	–	﹤0.01%	239
2019 Q2	$7K	Hold	24	–	–	0.01%	214
2019 Q1	$5K	Hold	24	–	–	﹤0.01%	217
2018 Q4	$4K	Buy	+24	New	+$4.92K	﹤0.01%	234

Other funds holding IDXX

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

BST

Bath Savings Trust Bath, Maine $966M AUM 9.35% 1-Year Est. Return

BRCM

Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

BAM

Bell Asset Management Melbourne, Australia $277M AUM 2.32% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

RSC

Red Spruce Capital Berwyn, Pennsylvania $283M AUM 29.49% 1-Year Est. Return

BSB

Bangor Savings Bank Bangor, Maine $1.31B AUM 12.25% 1-Year Est. Return

Acima Private Wealth's IDXX Position: Q3 2026 in Review

Acima Private Wealth reduced its Idexx Laboratories (IDXX) stake by 8.9% in Q3 2026, selling an estimated $24.1K and leaving 449 shares worth $234K. The position accounts for 0.07% of the portfolio, ranked #106.

Acima Private Wealth first reported a position in IDXX in Q4 2018 and has held it in 20 quarters since. The position peaked at $334K in Q4 2025. 33 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

Acima Private Wealth held 449 shares of Idexx Laboratories worth $234K as of Q3 2026.
Acima Private Wealth sold 44 Idexx Laboratories shares in Q3 2026, an estimated $24.1K.
Idexx Laboratories made up 0.07% of Acima Private Wealth's portfolio in Q3 2026, its #106 holding.
Acima Private Wealth first reported a position in Idexx Laboratories in Q4 2018 and has held it in 20 quarters since.
Acima Private Wealth's Idexx Laboratories position peaked at $334K in Q4 2025.
33 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Acima Private Wealth's 13F filing for Q3 2026, filed 5 Oct 2026.